GLOSSARY

Sodium Bicarbonate provides bicarbonate, commonly as sodium bicarbonate, to support extracellular buffering in selected exercise settings.

Sodium bicarbonate increases extracellular buffering availability and can benefit selected demanding exercise tasks. Individual timing and gastrointestinal tolerance are major practical constraints, and the sodium load matters. Nausea, abdominal discomfort or diarrhea can cancel a potential benefit. Bicarbonate is not simply an agent that removes all lactate, and lactate itself is not the sole cause of fatigue. Alternative buffering compounds and formulations need their own evidence; they should not be assumed interchangeable on the basis of a shared marketing category.

Beta-alanine is a precursor of carnosine, which contributes to intracellular hydrogen-ion buffering in muscle. Its purpose is to increase carnosine over repeated intake, rather than provide a necessary immediate pre-workout sensation. Benefits are task-dependent and should be distinguished between exercise-capacity tests and competition performance. Tingling after a dose is a known tolerability issue, not evidence that the product is working. Divided or sustained-release delivery can affect tolerability, while larger acute doses do not replace the cumulative loading process.

Supplement safety depends on ingredient, dose, duration, health status and other exposures. Natural origin does not guarantee safety, and absence of a reported adverse event in a small trial does not establish long-term safety. Medication interactions, pregnancy, age and kidney or liver disease can change the decision. Distinguish an event occurring during use from a causally established adverse effect. New or severe symptoms require stopping the suspect exposure and appropriate assessment rather than increasing the dose to overcome poor tolerance.

Apparent individual responses combine biological variation, measurement error, expectations and changes in training or diet. A person classified as a nonresponder after one noisy test may not have a stable absence of benefit. Use repeated, relevant observations under comparable conditions and consider starting nutrient status or habitual intake. Genetic mechanisms can be informative without making a commercial genetic test a validated prescription. Individualization should improve a practical decision, not turn uncertain differences into permanent athlete labels.

A credible supplement claim needs relevant controlled evidence, an appropriate comparison and a meaningful outcome. Randomization, placebo control and blinding reduce different sources of bias but do not guarantee a useful result. Sample size, uncertainty, training status, sex, diet and protocol affect interpretation. A pooled estimate is not a promise to every individual. Mechanistic plausibility, a changed biomarker, exercise capacity and actual competition performance are distinct levels of information that should not be treated as interchangeable.